Cipla’s capabilities in Active Pharmaceutical Ingredients - APIs
- A pioneer in API manufacturing in India for over 5 decades, Cipla currently manufactures more than 200 generic and complex APIs. Cipla APIs cover a broad spectrum of therapeutic categories that are supplied to some of the major formulation players in the pharmaceutical industry globally - over 350 Drug Master Files (DMF) and 70 Certificate of suitability of Monographs of the European Pharmacopoeia (CEPs).
- In addition, Cipla has a robust pipeline of over 50 APIs at various stages of development.
- Cipla maintains long-standing relationships with its existing partners on several APIs to support them in establishing leading positions for their markets.
- Cipla takes pride in its network of modern API manufacturing facilities, all approved by the US FDA and other major international regulatory agencies. The company also maintains the most stringent international standards of quality for all its products.